Recombinant herpes simplex gb-gd vaccine

Details Recombinant herpes simplex gb-gd vaccine Recombinant herpes simplex gb-gd vaccine

1989-10-02

1992-12-15

Wax, Robert A.

Drug, bio-affecting and body treating compositions

Lymphokine

424450, 4352351, 514 8, A61K 39245

Patent

active

051715686

ABSTRACT:
Vaccines and therapeutic compositions and methods for their production and use against Herpes Simplex Virus (HSV) are provided employing recombinant HSV glycoproteins B and D.
The following E. coli HB 101 strains were deposited at the A.T.C.C., where the plasmid indicates the plasmid employed to transform the strain; pH203; pHS112; pHS114; pHS127A and pHS206 were deposited on Apr. 4, 1984, and assigned Accession Nos. 39649-39653, respectively; pYHS109 and pYHS118 were deposited on Jul. 11, 1984, and given Accession Nos. 39762 and 39763, respectively.

REFERENCES:
patent: 4317811 (1982-03-01), Bertland et al.
patent: 4323559 (1982-04-01), Audibert et al.
patent: 4374127 (1983-02-01), Larson et al.
patent: 4396607 (1983-08-01), Lefrancier et al.
patent: 4406890 (1983-09-01), Tarcsay et al.
patent: 4452734 (1984-06-01), Larson et al.
patent: 4606918 (1986-08-01), Allison et al.
patent: 4618578 (1986-10-01), Burke et al.
patent: 4642333 (1987-02-01), Person
patent: 4661349 (1987-04-01), Kino et al.
patent: 4724146 (1988-02-01), Kino et al.
patent: 4762708 (1988-08-01), Cohen et al.
patent: 4818694 (1989-04-01), Watson et al.
patent: 4855224 (1989-08-01), Berman et al.
patent: 4891315 (1990-01-01), Watson et al.
Mertz et al., J. Infect. Dis. (1990) 161:653-660.
Kutinova et al., Vaccine (1988) 6:223-228.
Skinner et al., Med. Microbiol. Immunol. (1987) 176:161-168.
Blacklaws et al., Virology (1990) 177:727-736.
Stanberry et al., J. Infect. Dis. (1987) 155(5):914-920.
Stanberry et al., J. gen. Virol. (1989) 70:3177-3185.
Weis et al., Nature (1983) 302:72-74.
Berman et al., Science (1983) 222:524-527.
Laskey et al., Biotechnology (Jun. 1984) pp. 527-532.
De Luca et al., Virology (1982) 122:411-423.
Cappel et al., J. Medical. Virol. (1985) 16:137-145.
Pellett et al., J. Virol. (1985) 53(1):243-253.
Bzik et al., Virology (1984) 133:301-314.
Chan, Immunology (1983) 49:343-352.
Hilfenhaus et al., Devel. Biol. Standard. (1982) 52:321-331.
Roizman et al., Devel. Biol. Standard. (1982) 52:287-304.
Watson et al., Science (1982) 218:381-384.
Cohen et al., J. Virol. (1984) 49:102-108.
Dundarov et al., Devel. Biol. Standard. (1982) 52:351-357.
Skinner et al., Devel. Biol. Standard. (1982) 52:333-344.
Eberle et al., J. Infect. Dis. (1983) 148(3):436-444.
Marsden et al., J. Virol. (1978) 28(2):624-642.
Ruyechan et al., J. Virol. (1979) 29(2):677-697.
Skare et al., Virology (1977) 76:581-595.
Roizman et al., Ann. Rev. Genetics (1979) 13:25-57.
Berman et al., Science (1985) 227:1490-1492.

Affiliated with

Also associated with

Rating

Recombinant herpes simplex gb-gd vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant herpes simplex gb-gd vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant herpes simplex gb-gd vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2091447